Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers - Archive ouverte HAL Access content directly
Journal Articles Bone Marrow Transplantation Year : 2020

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Sylvain Garciaz
Remy Gressin
  • Function : Author
Remy Morello
  • Function : Author

Dates and versions

hal-02500667 , version 1 (06-03-2020)

Identifiers

Cite

Thomas Hueso, Thomas Gastinne, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Delette, et al.. Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers. Bone Marrow Transplantation, 2020, 55 (6), pp.1076-1084. ⟨10.1038/s41409-020-0783-y⟩. ⟨hal-02500667⟩
101 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More